Biogen Inc. (BIIB) Q4 2014 Earnings Results

Biogen Beats on EPS, Stock Up 0.59%

Biogen's earnings report shows a solid EPS performance, exceeding expectations by 9.36%. The stock reacted positively, rising 0.59%, likely reflecting investor confidence in the company's ongoing projects and management's optimistic tone. However, the lack of revenue data and guidance leaves some uncertainty about future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$4.09	N/A	+9.36%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding the company's performance. They emphasized the importance of their ongoing projects.

Management expressed satisfaction with the EPS performance despite not providing revenue figures.

They highlighted ongoing efforts in research and development as a key focus.

Biogen Beats on EPS, Stock Up 0.59%

Key numbers

Management commentary

Biogen Inc.

More earnings this week

Biogen Beats on EPS, Stock Up 0.59%

Key numbers

Management commentary